Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection

References

• Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–2063. doi:10.1016/S0140-6736(14)60220-8
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45(4):1056–1075. doi:10.1002/hep.21627
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–539. doi:10.1002/hep.21513
   PubMed Web of Science ®Google Scholar
• Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virol J. 2014;11:1–8. doi:10.1186/1743-422X-11-22
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61(12):1754–1764. doi:10.1136/gutjnl-2011-301073
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Tan AT, Gehring AJ. HBV-specific adaptive immunity. Viruses. 2009;1(2):91–103. doi:10.3390/v1020091
   PubMed Web of Science ®Google Scholar
• Ferrari C. HBV and the immune response. Liver Inter. 2015;35:121–128. doi:10.1111/liv.12749
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Di Bisceglie AM. The progression of hepatitis B–and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis. Med Clin. 2005;89(2):371–389. doi:10.1016/j.mcna.2004.08.014
   Google Scholar
• Fong TL, Di Bisceglie AM, Biswas R, et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol. 1994;43(2):155–158. doi:10.1002/jmv.1890430210
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999;284(5415):825–829. doi:10.1126/science.284.5415.825
   PubMed Web of Science ®Google Scholar
• Li X, Liu X, Tian L, Chen Y. Cytokine-mediated immunopathogenesis of hepatitis B virus infections. Clin Rev Allergy Immunol. 2016;50:41–54. doi:10.1007/s12016-014-8465-4
   PubMed Web of Science ®Google Scholar
• Ben-Ari Z, Mor E, Papo O, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol. 2003;98(1):144. doi:10.1111/j.1572-0241.2003.07179.x
   PubMed Web of Science ®Google Scholar
• Isorce N, Testoni B, Locatelli M, et al. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus. Antiviral Res. 2016;130:36–45. doi:10.1016/j.antiviral.2016.03.008
   PubMed Web of Science ®Google Scholar
• Isorce N, Lucifora J, Zoulim F, Durantel D. Immune-modulators to combat hepatitis B virus infection: from IFN-α to novel investigational immunotherapeutic strategies. Antiviral Res. 2015;122:69–81. doi:10.1016/j.antiviral.2015.08.008
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cobleigh MA, Lian JQ, et al. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology. 2011;141(5):1897–1906. doi:10.1053/j.gastro.2011.06.051
   PubMed Web of Science ®Google Scholar
• Xiong S-Q, Lin B-L, Gao X, Tang H, Wu C-Y. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers. Int Immunopharmacol. 2007;7(5):578–587. doi:10.1016/j.intimp.2006.12.007
   PubMed Web of Science ®Google Scholar
• Chen Y-HN, Chang M-H, Chiu Y-C, Chen H-L, Ni Y-H, Chang M-H. The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection. J Immunol. 2015;194(2):690–696. doi:10.4049/jimmunol.1401659
   PubMed Web of Science ®Google Scholar
• Schurich A, Pallett LJ, Lubowiecki M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 2013;9(3):e1003208. doi:10.1371/journal.ppat.1003208
   PubMed Web of Science ®Google Scholar
• Schultz-Thater E, Frey DM, Margelli D, et al. Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR: a versatile monitoring and discovery tool. J Transl Med. 2008;6:1–9. doi:10.1186/1479-5876-6-58
   PubMed Web of Science ®Google Scholar
• Zhang K, Xu Q-H, Chen L-B, Shu X, Chen N, Li G. Correlation of serum chemokine RANTES level with serum biochemical indices, HBeAg and HBV DNA load in patients with chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi. 2009;23(3):188–190.
   PubMedGoogle Scholar
• Liu C, Huang X, Werner M, et al. Elevated expression of chemokine CXCL13 in chronic hepatitis B patients links to immune control during antiviral therapy. Front Immunol. 2017;8:323. doi:10.3389/fimmu.2017.00323
   PubMed Web of Science ®Google Scholar
• Sanchooli J, Sanadgol N, Kazemi Arababadi M, Kennedy D. CCR5 plays important roles in hepatitis B infection. Viral Immunol. 2014;27(1):2–6. doi:10.1089/vim.2013.0067
   PubMed Web of Science ®Google Scholar
• Li X, Wang Y, Chen Y. Cellular immune response in patients with chronic hepatitis B virus infection. Microb Pathog. 2014;74:59–62. doi:10.1016/j.micpath.2014.07.010
   PubMed Web of Science ®Google Scholar
• Sun H, Zhou D, Zhou JY. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. J Med Virol. 2016;88(1):13–20. doi:10.1002/jmv.24306
   PubMed Web of Science ®Google Scholar
• Ma YJ, He M, Han JA, Yang L, Ji XY. A Clinical Study of HB sAg‐activated dendritic cells and cytokine‐induced killer cells during the treatment for chronic hepatitis B. Scand J Immunol. 2013;78(4):387–393. doi:10.1111/sji.12097
   PubMed Web of Science ®Google Scholar
• Figdor CG, Van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002;2(2):77–84. doi:10.1038/nri723
   PubMed Web of Science ®Google Scholar
• Van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Innate signaling and regulation of dendritic cell immunity. Curr Opin Immunol. 2007;19(4):435–440. doi:10.1016/j.coi.2007.05.006
   PubMed Web of Science ®Google Scholar
• van der Molen RG, Sprengers D, Binda RS, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology. 2004;40(3):738–746. doi:10.1002/hep.20366
   PubMed Web of Science ®Google Scholar
• Duan XZ, Zhuang H, Wang M, Li HW, Liu JC, Wang FS. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol. 2005;20(2):234–242. doi:10.1111/j.1440-1746.2004.03529.x
   PubMed Web of Science ®Google Scholar
• Bozdayi A, Uzunalimoğlu Ö, Türkyilmaz A, et al. YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine. J Viral Hepat. 2003;10(4):256–265. doi:10.1046/j.1365-2893.2003.00435.x
   PubMed Web of Science ®Google Scholar
• Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14(10):996–1006. doi:10.1038/ni.2691
   PubMed Web of Science ®Google Scholar
• Hou X, Hao X, Zheng M, et al. CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells. Cell Mol Immunol. 2017;14(8):675–684. doi:10.1038/cmi.2015.111
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao W, Cheng L, et al. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol. 2010;185(12):7654–7662. doi:10.4049/jimmunol.1000927
   PubMed Web of Science ®Google Scholar
• Li M, Sun R, Xu L, et al. Kupffer cells support hepatitis B virus–mediated CD8+ T cell exhaustion via hepatitis B core antigen–TLR2 interactions in mice. J Immunol. 2015;195(7):3100–3109. doi:10.4049/jimmunol.1500839
   PubMed Web of Science ®Google Scholar
• Hu S, Liu X, Gao Y, et al. Hepatitis B virus inhibits neutrophil extracellular trap release by modulating reactive oxygen species production and autophagy. J Immunol. 2019;202(3):805–815. doi:10.4049/jimmunol.1800871
   PubMed Web of Science ®Google Scholar
• Takai S, Kimura K, Nagaki M, Satake S, Kakimi K, Moriwaki H. Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice. J Virol. 2005;79(24):15142–15150. doi:10.1128/JVI.79.24.15142-15150.2005
   PubMed Web of Science ®Google Scholar
• Xu R, Huang H, Zhang Z, Wang F-S. The role of neutrophils in the development of liver diseases. Cell Mol Immunol. 2014;11(3):224–231. doi:10.1038/cmi.2014.2
   PubMed Web of Science ®Google Scholar
• Doherty DG, O’Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 2000;174:5–20. doi:10.1034/j.1600-0528.2002.017416.x
   PubMed Web of Science ®Google Scholar
• Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an under investigated innate immune response. J Viral Hepat. 2005;12(1):38–45. doi:10.1111/j.1365-2893.2005.00543.x
   PubMed Web of Science ®Google Scholar
• Wu SF, Wang WJ, Gao YQ. Natural killer cells in hepatitis B virus infection. Braz J Infect Dis. 2015;19:417–425. doi:10.1016/j.bjid.2015.05.006
   PubMed Web of Science ®Google Scholar
• Schuch A, Hoh A, Thimme R. The role of natural killer cells and CD8+ T cells in hepatitis B virus infection. Front Immunol. 2014;5:258. doi:10.3389/fimmu.2014.00258
   PubMed Web of Science ®Google Scholar
• Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology. 2008;47(2):729–736. doi:10.1002/hep.22034
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology. 2011;53(1):73–85.
   PubMed Web of Science ®Google Scholar
• Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK/STAT pathway. Prot Sci. 2018;27(12):1984–2009. doi:10.1002/pro.3519
   PubMed Web of Science ®Google Scholar
• Xu X, Shang Q, Chen X, et al. Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients. Cell Mol Immunol. 2015;12(3):309–316. doi:10.1038/cmi.2015.25
   PubMed Web of Science ®Google Scholar
• Farci P, Diaz G, Chen Z, et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure. Proc Natl Acad Sci. 2010;107(19):8766–8771. doi:10.1073/pnas.1003854107
   PubMed Web of Science ®Google Scholar
• Ciupe SM, Ribeiro RM, Perelson AS. Antibody responses during hepatitis B viral infection. PLoS Comput Biol. 2014;10(7):e1003730. doi:10.1371/journal.pcbi.1003730
   PubMed Web of Science ®Google Scholar
• Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med. 2000;191(8):1269–1280. doi:10.1084/jem.191.8.1269
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Morris A, Mendez H, et al. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol. 2002;76(6):2617–2621. doi:10.1128/JVI.76.6.2617-2621.2002
   PubMed Web of Science ®Google Scholar
• Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209(6):1201–1217. doi:10.1084/jem.20112741
   PubMed Web of Science ®Google Scholar
• Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2018;18(3):153–167. doi:10.1038/nri.2017.108
   PubMed Web of Science ®Google Scholar
• Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion during chronic viral infection by multiple inhibitory receptors. Nat Immunol. 2009;10(1):29. doi:10.1038/ni.1679
   PubMed Web of Science ®Google Scholar
• Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol. 2008;45(4):963–970. doi:10.1016/j.molimm.2007.07.038
   PubMed Web of Science ®Google Scholar
• Mahdi Y, Kadhim H. Evaluation of cytotoxic T-lymphocyte Antigen-4 (+ 49A/G) gene polymorphism in chronic hepatitis B virus infection. Iraqi JMS. 2020;18(2):101–109. doi:10.22578/IJMS.18.2.3
   Google Scholar
• Cho H, Kang H, Lee HH, Kim CW. Programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in viral hepatitis. Int J Mol Sci. 2017;18(7):1517. doi:10.3390/ijms18071517
   PubMed Web of Science ®Google Scholar
• Thimme R, Wieland S, Steiger C, et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77(1):68–76. doi:10.1128/JVI.77.1.68-76.2003
   PubMed Web of Science ®Google Scholar
• Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest. 1997;99(7):1472–1477. doi:10.1172/JCI119308
   PubMed Web of Science ®Google Scholar
• Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol. 2010;184(1):287–295. doi:10.4049/jimmunol.0902761
   PubMed Web of Science ®Google Scholar
• Marinos G, Torre F, Chokshi S, et al. Induction of T‐helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology. 1995;22(4):1040–1049. doi:10.1002/hep.1840220405
   PubMedGoogle Scholar
• Milich D. Influence of T‐helper cell subsets and cross regulation in hepatitis B virus infection. J Viral Hepat. 1997;4:48–59. doi:10.1111/j.1365-2893.1997.tb00180.x
   PubMed Web of Science ®Google Scholar
• Xing T, Xu H, Yu W. Role of T follicular helper cells and their associated molecules in the pathogenesis of chronic hepatitis B virus infection. Exp Ther Med. 2013;5(3):885–889. doi:10.3892/etm.2012.864
   PubMed Web of Science ®Google Scholar
• Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008;123(1):57–65. doi:10.1111/j.1365-2567.2007.02691.x
   PubMed Web of Science ®Google Scholar
• Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006;177(1):739–747. doi:10.4049/jimmunol.177.1.739
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Viglietta V, Hafler DA. The potential for targeting CD4+ CD25+ regulatory T cells in the treatment of multiple sclerosis in humans. Regul T Cells Inflam. 2005;2005:133–151.
   Google Scholar
• Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+ CD25+ immunoregulatory cells. J Immunol. 2001;167(3):1137–1140. doi:10.4049/jimmunol.167.3.1137
   PubMed Web of Science ®Google Scholar